Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,108 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,158)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00268684 | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC | unknown | Phase 3 | 381 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 28, 2006 | clinicaltrials |
| NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | unknown | Phase 2 / Phase 3 | 286 | Charite University, Berlin, GermanyOTHER | 1 | Feb 14, 2006 | clinicaltrials |
| NCT00289263 | Maintenance Chemotherapy in Metastatic Breast Cancer | unknown | Phase 3 | 524 | MANTA 1 Study Italian Collaborative GroupOTHER | 1 | Feb 9, 2006 | clinicaltrials |
| NCT00088660 | PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen | unknown | Phase 3 | 250 | Therion Biologics CorporationINDUSTRY | 1 | Feb 8, 2006 | clinicaltrials |
| NCT00193817 | Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial | unknown | Phase 3 | 700 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 7, 2006 | clinicaltrials |
| NCT00139971 | Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer | unknown | Phase 3 | 600 | West Japan Thoracic Oncology GroupOTHER | 1 | Jan 6, 2006 | clinicaltrials |
| NCT00265694 | Random Trial for Elderly Patients With NSCLC | unknown | Phase 3 | — | Inje UniversityOTHER | 1 | Dec 15, 2005 | clinicaltrials |
| NCT00224614 | Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia | unknown | Phase 3 | 100 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 14, 2005 | clinicaltrials |
| NCT00165048 | Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial | unknown | Phase 3 | 206 | Chinese University of Hong KongOTHER | 1 | Dec 9, 2005 | clinicaltrials |
| NCT00189631 | UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Dec 8, 2005 | clinicaltrials |
| NCT00154752 | Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer | unknown | Phase 3 | 200 | National Taiwan University HospitalOTHER | 1 | Nov 22, 2005 | clinicaltrials |
| NCT00209833 | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T | unknown | Phase 2 / Phase 3 | 200 | Hannover Medical SchoolOTHER | 1 | Nov 18, 2005 | clinicaltrials |
| NCT00164892 | Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial | unknown | Phase 3 | 214 | Chinese University of Hong KongOTHER | 1 | Nov 17, 2005 | clinicaltrials |
| NCT00078598 | A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma | unknown | Phase 3 | 506 | Corixa CorporationINDUSTRY | 1 | Nov 9, 2005 | clinicaltrials |
| NCT00121914 | Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone | unknown | Phase 3 | 120 | Medical University of ViennaOTHER | 1 | Oct 18, 2005 | clinicaltrials |
| NCT00201630 | Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy | unknown | Phase 3 | 150 | New York Prostate InstituteOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00189644 | 6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 0 | Sep 19, 2005 | clinicaltrials |
| NCT00189657 | 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
| NCT00189683 | Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
| NCT00164918 | Role of Routine Nasogastric Decompression After Subtotal Gastrectomy | unknown | Phase 3 | 90 | Chinese University of Hong KongOTHER | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00002318 | A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma | unknown | Phase 3 | 225 | Sequus PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00052130 | Vaccine Therapy for Patients With Stage III Melanoma | unknown | Phase 3 | 1,118 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00052156 | Vaccine Therapy for Patients With Stage IV Melanoma | unknown | Phase 3 | 670 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Feb 28, 2006source: clinicaltrials